Diagnostic Electrocardiograph (ECG) Market

Executive Summary

Diagnostic Electrocardiograph (ECG) Market was valued at US $7.98 billion in 2021 and is projected to grow at 5.66% CAGR over the forecast period to reach US $11.10 billion by 2027. Diagnostic Electrocardiograph (ECG) Market represented US $0.83 billion opportunity over 2019-2021 and estimated to create US $3.12 billion opportunity in 2027 over 2021.

Diagnostic Electrocardiograph (ECG) from Consainsights analyses the Diagnostic Electrocardiograph (ECG) Market in the Life Sciences industry over the forecast period to 2027.

Diagnostic Electrocardiograph (ECG) research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Diagnostic Electrocardiograph (ECG) segmentation includes Product & Service, Lead Type, End User, Region and Geography.

Based on the Product & Service, the Diagnostic Electrocardiograph (ECG) analysis covers Products, Resting ECG Devices, Stress ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Event Monitors, Holter Monitors, Smart ECG Monitors, Software & Services.

In Product & Service segment, Products segment has highest cagr growth of 5.02%.

Based on the Lead Type, the Diagnostic Electrocardiograph (ECG) analysis covers 12-Lead ECG Devices, 5-Lead ECG Devices, 3-Lead ECG Devices, 6-Lead ECG Devices, Single-Lead ECG Devices, Other Lead Types.

In Lead Type segment, 12-Lead ECG Devices segment has highest cagr growth of 5.02%.

Based on the End User, the Diagnostic Electrocardiograph (ECG) analysis covers Hospitals, Clinics, and Cardiac Centers, Ambulatory Surgical Centers, Other End Users.

In End User segment, Hospitals, Clinics, and Cardiac Centers segment has highest cagr growth of 5.02%.

Based on the Region, the Diagnostic Electrocardiograph (ECG) analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 5.02%.

Based on the region, the Diagnostic Electrocardiograph (ECG) analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Hill-Rom Holdings, Inc., MBU A/S, Schiller AG, ACS Diagnostics, BPL Technologies, Fukuda Denshi, Biotelemetry, Inc., OSI Systems, Inc., BTL, Allengers Medical Systems, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Edan Instruments, Inc., Cardioline Spa, Suzuken Co., Ltd., Norav Medical, Bionet Co., Inc., Vectracor, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product & Service

Introduction

In 2021, Products segment has the highest revenue of US $3.07 billion and is expected to grow at CAGR of 5.02% by 2027 Products segment has highest cagr growth of 5.02%.

Products

Products segment was valued at US $2.75 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $4.28 billion by 2027. Products segment represented US $0.32 billion opportunity over 2019-2021 and estimated to create US $1.20 billion opportunity in 2027 over 2021.

Resting ECG Devices

Resting ECG Devices segment was valued at US $1.72 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $2.67 billion by 2027. Resting ECG Devices segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.75 billion opportunity in 2027 over 2021.

Stress ECG Devices

Stress ECG Devices segment was valued at US $1.08 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $1.69 billion by 2027. Stress ECG Devices segment represented US $0.13 billion opportunity over 2019-2021 and estimated to create US $0.47 billion opportunity in 2027 over 2021.

Implantable Loop Recorders

Implantable Loop Recorders segment was valued at US $0.67 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $1.05 billion by 2027. Implantable Loop Recorders segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Mobile Cardiac Telemetry Devices

Mobile Cardiac Telemetry Devices segment was valued at US $0.43 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.67 billion by 2027. Mobile Cardiac Telemetry Devices segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.19 billion opportunity in 2027 over 2021.

Event Monitors

Event Monitors segment was valued at US $0.23 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.36 billion by 2027. Event Monitors segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.

Holter Monitors

Holter Monitors segment was valued at US $0.15 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.23 billion by 2027. Holter Monitors segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Smart ECG Monitors

Smart ECG Monitors segment was valued at US $0.06 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.10 billion by 2027. Smart ECG Monitors segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

Software & Services

Software & Services segment was valued at US $0.04 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.06 billion by 2027. Software & Services segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.02 billion opportunity in 2027 over 2021.

Lead Type

Introduction

In 2021, 12-Lead ECG Devices segment has the highest revenue of US $3.33 billion and is expected to grow at CAGR of 5.02% by 2027 12-Lead ECG Devices segment has highest cagr growth of 5.02%.

12-Lead ECG Devices

12-Lead ECG Devices segment was valued at US $2.98 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $4.64 billion by 2027. 12-Lead ECG Devices segment represented US $0.35 billion opportunity over 2019-2021 and estimated to create US $1.30 billion opportunity in 2027 over 2021.

5-Lead ECG Devices

5-Lead ECG Devices segment was valued at US $1.59 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $2.48 billion by 2027. 5-Lead ECG Devices segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.70 billion opportunity in 2027 over 2021.

3-Lead ECG Devices

3-Lead ECG Devices segment was valued at US $1.22 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $1.90 billion by 2027. 3-Lead ECG Devices segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.53 billion opportunity in 2027 over 2021.

6-Lead ECG Devices

6-Lead ECG Devices segment was valued at US $0.57 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.88 billion by 2027. 6-Lead ECG Devices segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

Single-Lead ECG Devices

Single-Lead ECG Devices segment was valued at US $0.45 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.69 billion by 2027. Single-Lead ECG Devices segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.20 billion opportunity in 2027 over 2021.

Other Lead Types

Other Lead Types segment was valued at US $0.33 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.51 billion by 2027. Other Lead Types segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.14 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals, Clinics, and Cardiac Centers segment has the highest revenue of US $3.80 billion and is expected to grow at CAGR of 5.02% by 2027 Hospitals, Clinics, and Cardiac Centers segment has highest cagr growth of 5.02%.

Hospitals, Clinics, and Cardiac Centers

Hospitals, Clinics, and Cardiac Centers segment was valued at US $3.40 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $5.28 billion by 2027. Hospitals, Clinics, and Cardiac Centers segment represented US $0.40 billion opportunity over 2019-2021 and estimated to create US $1.49 billion opportunity in 2027 over 2021.

Ambulatory Surgical Centers

Ambulatory Surgical Centers segment was valued at US $2.40 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $3.72 billion by 2027. Ambulatory Surgical Centers segment represented US $0.28 billion opportunity over 2019-2021 and estimated to create US $1.05 billion opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $1.35 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $2.09 billion by 2027. Other End Users segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.59 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $3.98 billion and is expected to grow at CAGR of 5.02% by 2027 North America segment has highest cagr growth of 5.02%.

North America

North America segment was valued at US $3.56 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $5.53 billion by 2027. North America segment represented US $0.41 billion opportunity over 2019-2021 and estimated to create US $1.56 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $1.74 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $2.70 billion by 2027. Europe segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.76 billion opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $1.77 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $2.76 billion by 2027. Asia Pacific segment represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.78 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.07 billion in 2019 and is projected to grow at 5.02% CAGR over the forecast period to reach US $0.11 billion by 2027. Rest of the World segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.